Andrew D. Luber

Dr. Luber is a clinical pharmacist/pharmacologist with over 20 years of experience in drug development and clinical research. As Executive Director of Research for both Pacific Oaks Medical Group and Tower ID Research in Los Angeles, CA, Dr. Luber was a clinical investigator in more than 70 clinical trials, including 4 Phase 1a/b studies. Dr. Luber has authored textbook chapters and numerous articles in peer-reviewed journals and on-line resources in the area of HIV Pharmacology and Pharmacokinetics and helped to develop the American Academy of HIV Medicine’s (AAHIVM) Self-Directed Study Guide by authoring the Pharmacology and Pharmacokinetic sections. In addition, he was a core faculty member that worked to develop The Viral Hepatitis Mid-Level Provider Certification Program for the American Association for Study of Liver Diseases (AASLD). Dr. Luber has worked with many different pharmaceutical companies as an investigator, speakers’ bureau, steering committee and advisory board member, as well as serving as a clinical consultant to both large and early stage pharmaceutical companies. Dr Luber received his B.S. Pharm and Pharm.D. from Temple University School of Pharmacy, Philadelphia PA. He completed his residency in both pharmacy practice and infectious diseases, as well his research fellowship in infectious diseases pharmacotherapy, at the University of California, San Francisco, School of Pharmacy, San Francisco, California.